However, the development and production of high concentration formulations still face multiple technical bottlenecks: viscosity increases exponentially with concentration, the risk of polymer formation increases, drug solubility is insufficient, and stability decreases. This not only increases the difficulty of formulation development, but also poses risks to subsequent process amplification, aseptic filling, and clinical use. Systematic solutions are urgently needed to ensure product quality and production efficiency.

Based on this, this forum focuses on high concentration subcutaneous drug delivery biologics, inviting front-line technical personnel and industry senior experts from enterprises to share practical experience and solutions around core aspects such as development prospects, development challenges, process optimization, and strategy implementation, helping enterprises break through technical barriers, accelerate the industrialization of biologics projects, and promote high-quality development of the industry.